Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8906890 | BAYER HLTHCARE | Very low-dosed solid oral dosage forms for HRT |
Oct, 2031
(8 years from now) |
Market Authorisation Date: 28 September, 2005
Treatment: NA
Dosage: TABLET;ORAL
3
United States
3
European Union
2
Korea, Republic of
1
Canada
1
Mexico
1
Guatemala
1
Argentina
1
Brazil
1
China
1
Australia
1
Colombia
1
EA
1
Uruguay
1
Japan
1
Costa Rica
1
Taiwan
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic